Polyphenolic Additives in Sequencing by Synthesis

US2019330690A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019330690-A1
Application numberUS-201916422056-A
CountryUS
Kind codeA1
Filing dateMay 24, 2019
Priority dateFeb 11, 2016
Publication dateOct 31, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the efficiency of Sequencing-By-Synthesis reactions. For example, gallic acid (GA) is shown herein to be one of many exemplary SBS polyphenolic additives.

First claim

Opening claim text (preview).

1 - 14 . (canceled) 15 . A method of incorporating labeled nucleotides, comprising: a) providing i) a plurality of nucleic acid primers and template molecules, ii) a polymerase, iii) a cleave reagent comprising a reducing agent and the polyphenolic compound gentisic acid, and iv) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base; b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers; c) incorporating a first labeled nucleotide analogue with said polymerase into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated labeled nucleotide analogue; d) detecting said incorporated labeled nucleotide analogue; and e) cleaving the cleavable linker of said incorporated nucleotide analogues with said cleave reagent. 16 . The method of claim 15 , wherein said reducing agent of said cleave reagent comprises TCEP (tris(2-carboxyethyl)phosphine). 17 . The method of claim 15 , wherein said incorporated nucleotide analogues of step c) further comprise a removable chemical moiety capping the 3′-OH group. 18 . The method of claim 16 , wherein the cleaving of step e) removes the removable chemical moiety capping the 3′-OH group. 19 . The method of claim 18 , wherein the method further comprises: f) incorporating a second nucleotide analogue with said polymerase into at least a portion of said extended primers. 20 . The method of claim 15 , wherein said label is fluorescent. 21 . A method of incorporating labeled nucleotides, comprising: a) providing i) a plurality of nucleic acid primers and template molecules, ii) a polymerase, iii) a cleave reagent comprising a reducing agent and the polyphenolic compound pryocatechol, and iv) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base; b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers; c) incorporating a first labeled nucleotide analogue with said polymerase into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated labeled nucleotide analogue; d) detecting said incorporated labeled nucleotide analogue; and e) cleaving the cleavable linker of said incorporated nucleotide analogues with said cleave reagent. 22 . The method of claim 21 , wherein said reducing agent of said cleave reagent comprises TCEP (tris(2-carboxyethyl)phosphine). 23 . The method of claim 21 , wherein said incorporated nucleotide analogues of step c) further comprise a removable chemical moiety capping the 3′-OH group. 24 . The method of claim 22 , wherein the cleaving of step e) removes the removable chemical moiety capping the 3′-OH group. 25 . The method of claim 24 , wherein the method further comprises: f) incorporating a second nucleotide analogue with said polymerase into at least a portion of said extended primers. 26 . The method of claim 21 , wherein said label is fluorescent. 27 . A method of incorporating labeled nucleotides, comprising: a) providing i) a plurality of nucleic acid primers and template molecules, ii) a polymerase, iii) a cleave reagent comprising a reducing agent and the polyphenolic compound pyrogallol, and iv) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base; b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers; c) incorporating a first labeled nucleotide analogue with said polymerase into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated labeled nucleotide analogue; d) detecting said incorporated labeled nucleotide analogue; and e) cleaving the cleavable linker of said incorporated nucleotide analogues with said cleave reagent. 28 . The method of claim 27 , wherein said reducing agent of said cleave reagent comprises TCEP (tris(2-carboxyethyl)phosphine). 29 . The method of claim 27 , wherein said incorporated nucleotide analogues of step c) further comprise a removable chemical moiety capping the 3′-OH group. 30 . The method of claim 28 , wherein the cleaving of step e) removes the removable chemical moiety capping the 3′-OH group. 31 . The method of claim 30 , wherein the method further comprises: f) incorporating a second nucleotide analogue with said polymerase into at least a portion of said extended primers. 32 . The method of claim 27 , wherein said label is fluorescent.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019330690A1 cover?
The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the ef…
Who is the assignee on this patent?
Qiagen Sciences Llc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6823. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).